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Brachial circumference (BC), also known as upper arm or mid arm circumference, can be used as an indicator of muscle mass
and fat tissue, which are distributed differently in men and women. Analysis of anthropometric measures of peripheral fat
distribution such as BC could help in understanding the complex pathophysiology behind overweight and obesity. The
purpose of this study is to identify genetic variants associated with BC through a large-scale genome-wide association scan
(GWAS) meta-analysis. We used fixed-effects meta-analysis to synthesise summary results across 14 GWAS discovery and 4
replication cohorts comprising overall 22,376 individuals (12,031 women and 10,345 men) of European ancestry. Individual
analyses were carried out for men, women, and combined across sexes using linear regression and an additive genetic
model: adjusted for age and adjusted for age and BMI. We prioritised signals for follow-up in two-stages. We did not detect
any signals reaching genome-wide significance. The FTO rs9939609 SNP showed nominal evidence for association (p,0.05)
in the age-adjusted strata for men and across both sexes. In this first GWAS meta-analysis for BC to date, we have not
identified any genome-wide significant signals and do not observe robust association of previously established obesity loci
with BC. Large-scale collaborations will be necessary to achieve higher power to detect loci underlying BC.
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Brachial circumference (BC) is a composite measure of muscle
mass, skeletal size and fat tissue [1,2]. BC has been widely used in
epidemiological and clinical studies as a proxy for body composition
[3]. Analysis of anthropometric measures of peripheral fat distribu-
tion like BC could help in understanding complex phenotypes such as
overweight and obesity that can lead to the development of chronic
diseases, for example type 2 diabetes (T2D) and cardiovascular
disease [4,5,6]. Research of upper and lower body fat association with
diabetes in families of African origin suggested that arm and leg fat
could be used as obesity-related phenotypes in association studies [7].
Obesity in children can also lead to development of chronic diseases
such as hyperlipidaemia, hyperinsulinemia, hypertension, and early
atherosclerosislateroninlife[8].ItwasshownthatBCcloselyreflects
body fat mass in children and adolescents and its use was
recommended as a screening method for prediction of obesity and
overweight [3,8]. Moreover, BC has been used for decades for the
assessment of nutritional status of children in developing countries
and has also been proposed as a tool for monitoring nutritional status
and weight in the elderly [3,9,10,11]. Peripheral and overall fat
distribution, assessed through body mass index (BMI), is partly
modulated through different genetic effects [12].
There are differences in the amount and distribution pattern of
soft tissue between sexes. In general, men have higher total body
lean tissue and lower percent body fat whereas women have higher
total body fat and a lower proportion of lean tissue in the upper
body [1,13,14,15,16]. Women have more subcutaneous fat than
men over the buttocks and thighs and behind the upper arms [17].
In addition, it was recently shown that diabetic women of African
ancestry have a higher proportion of fat deposited in their arms
than diabetic men [7]. Due to the effects of sex hormones but also
due to heavier physical activity and involvement in more power
sports, men have larger muscle size/mass and larger BC compared
to women [17,18]. This may indicate that BC is a better measure
of muscularity in men and adipose tissue in women. Analysis of the
genetic contribution to BC in Belgian nuclear families indicated
that BC is influenced by additive genetic effects (h
2=0.57) [19].
Miljkovic-Gacic et al also estimated high heritability of upper arm
body fat storage and also pointed that genetic factors play a role in
defining sexual dimorphism of lower body fat distribution in
individuals of African origin [7]. Genetic effects on fat distribution
can be related to sex and in this study we aimed to evaluate sex-
specific genetic associations with BC through analysis of men and
women separately, as well as common associations through the
analysis of a combined dataset.
Weight gain and redistribution of fat tissue, the main
characteristics of aging, influence body composition and conse-
quently affect BC [20]. The decrease in BC that is observed in
elderly men and women points to substantial subcutaneous fat loss
and redistribution of fat from extremity to trunk [4]. Additionally,
aging is also characterised by loss in skeletal muscle mass, known
as sarcopenia [21,22]. To account for these effects of aging on BC
we adjusted all our analyses for the age of individuals.
In summary, BC is a measure of both adiposity and muscularity
[1]. This study aimed to identify shared and sex-specific genetic
variants associated with BC through a large-scale genome-wide
association scan (GWAS) meta-analysis.
Materials and Methods
Discovery dataset: sample characteristics
We conducted genome-wide meta-analysis across 14 discovery
datasets, comprising a total of 18,753 individuals (8,961 men,
9,792 women) of European ancestry. BC measurement was taken
uniformly across studies; it was measured in mm using non-elastic
tape that was wrapped around the upper arm, at the medium of
the upper arm length i.e. at the midpoint between the acromion
and the olecranon. BC was normally distributed. Individuals that
had BC higher or lower than 3 standard deviations from the mean
were removed from each dataset prior to conducting association
analysis. Sample characteristics across all datasets are presented in
Table 1. Detailed sample characteristics on men and women
separately are presented in Table S1. A bar chart of BC measures
across studies is presented in Figure S1.
Ethics Statement
Each study obtained ethical approval from their respective
research ethics committee and all participants gave signed
informed consent in accordance with the Declaration of Helsinki.
Genotyping, imputation and quality control
All samples were genotyped using commercially available
Illumina (Illumina, Inc., San Diego, CA, USA) or Affymetrix
(Affymetrix, Inc., Santa Clara, CA, USA) platforms. Imputation of
untyped variants was based on HapMap Phase II data for the
CEU population. Quality control (QC) of directly typed and
imputed variants was conducted separately in each study. Study-
specific information on genotyping platform, imputation method
and QC metrics is presented in Table S2.
Genome-wide association analysis in contributing studies
Association analysis was performed in each study separately.
Analyses were performed for directly typed and imputed
autosomal variants using linear regression and an additive genetic
model, adjusted for age and adjusted for age and BMI, in men and
women separately. Specifically, four types of analyses were carried
out: women – age adjusted, women – age and BMI adjusted, men
- age adjusted, men – age and BMI adjusted. By adjusting a set of
our analyses with BMI we aim to differentiate the effects of loci
solely influencing regional adiposity and/or muscularity. BC
changes throughout the life and by adjusting analyses for age we
aim to exclude the effect of age on BC. Association analyses of
imputed variants took genotype uncertainty into account. Where
necessary, the first three genotype-based principal components
were used as covariates. Studies with related individuals
additionally adjusted analyses for family relatedness using linear
mixed models. Association analysis software for each study is
presented in Table S2. Sensitivity analysis excluding the two
studies comprised of adolescent individuals (ALSPAC and
RAINE) was also carried out, to exclude potential effects of genes
that might be involved in body development and growth during
adolescence. We also investigated the effects of 54 previously
established genetic loci associated with overall adiposity, assessed
through BMI and other measures of fat distribution such as waist-
to-hip ratio, and peripheral adiposity, and of 64 previously
established T2D loci and 41 loci influencing glycaemic traits with
BC in discovery dataset.
GWAS meta-analysis
We performed six fixed-effects meta-analyses to synthesize
summary statistics across 14 datasets using GWAMA [23]. Meta-
analyses were performed separately in men and women but also in
the combined set. Prior to meta-analysis we excluded SNPs with
minor allele frequency (MAF) lower than 0.05 and SNPs with low
imputation accuracy scores. We used a cut-off of rsq_hat ,0.3 for
genotypes imputed with MACH [24] software and a cut-off of
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of directly genotyped and imputed SNPs that passed QC criteria
across all studies and were subsequently meta-analysed is
presented for each meta-analysis in Table S3. The genomic
control (GC) inflation factor was calculated and applied to the
results for each study separately, prior to the meta-analysis. The
meta-analysis results were also corrected for overall GC. We
investigated evidence of heterogeneity using the I
2 statistic [26].
We created quantile-quantile (QQ) and Manhattan plots to
visualise genome-wide association results.
Replication stage 1
On the basis of the GWAS meta-analysis results we conducted a
two-stage follow-up of prioritised SNPs in independent datasets.
The study design is presented in Figure 1.
We selected 31 SNPs for initial in silico replication: we focused
on SNPs with p-values below or close to 10
25 and additionally
examined their genomic location, prioritising those within or near
biologically interesting genes. When there were many SNPs with
p-values below 10
25 in the same genomic region we selected the
two most significant variants for follow-up. We visually inspected
cluster plots (in studies with available intensity data) for all selected
SNPs prior to replication.
Replication stage 1 samples included 967 subjects from the
Family Heart Study (FamHS) (Table 1 and Table S2) [27]. We
combined summary statistics for 31 directly typed and imputed
SNPs across the discovery and stage 1 replication studies using
fixed-effects meta-analysis. We performed the same sets of analyses
as described for the discovery dataset.
Replication stage 2
On the basis of meta-analysis results across the discovery and
replication stage 1 datasets, and taking into account the results of
our sensitivity analyses, we prioritised a subset of 22 SNPs for the
second round of replication. SNPs were selected primarily on the
basis of their overall statistical significance. We also selected the
established obesity variant rs9939609 in FTO to assess its
association with BC in a larger sample size. Overall, 23 SNPs
were taken forward for de novo genotyping in the Greek TEENs of
Attica: Genes & Environment (TEENAGE) study and in silico
replication in two studies, the Nord-Trøndelag Health Study
(HUNT) [28] and TwinFat [29,30]. The main reason for
conducting two stage replication was to refine significance of
initially prioritised SNPs using in silico data (replication stage 1) and
to select a subset of SNPs with greater evidence of association to fit
one genotyping multiplex (iPLEX
TM Gold Assay) for de novo
genotyping in the TEENAGE cohort (replication stage 2). Two
studies with in silico data (HUNT and TwinFat) joined the analysis
at the advanced stage of replication stage 2.
TEENAGE cohort. The TEENAGE cohort consists of 819
adolescent students attending all three classes of public secondary
schools in the Attica region of Greece (Table 1). Genotyping of the
23 prioritised SNPs was performed using the iPLEX
TM Gold
Assay (SequenomH Inc.). Assays for two SNPs (rs7837164 and
rs4833582) could not be designed, therefore their proxies
(rs4831616 and rs10018120 with r
2=1 and r
2=1, respectively)
were genotyped instead. Assays for all SNPs were designed using
the eXTEND suite and MassARRAY Assay Design software
version 3.1 (SequenomH Inc.). Amplification was performed in a
total volume of 5 mL containing ,0.06–0.4 ng genomic DNA,
100 nM of each PCR primer, 500 mM of each dNTP, 1.256PCR
buffer (Qiagen), 1.625 mM MgCl2 and 1 U HotStar TaqH
(Qiagen). Reactions were heated to 94uC for 15 min followed by
45 cycles at 94uC for 20 s, 56uC for 30 s and 72uC for 1 min, then
a final extension at 72uC for 3 min. Unincorporated dNTPs were
SAP digested prior to iPLEX
TM Gold allele specific extension with
mass-modified ddNTPs using an iPLEX Gold reagent kit
(SequenomH Inc.). SAP digestion and extension were performed
according to the manufacturer’s instructions with reaction
extension primer concentrations adjusted to between 0.7–
1.8 mM, dependent upon primer mass. Extension products were
desalted and dispensed onto a SpectroCHIP using a MassARRAY
Nanodispenser prior to MALDI-TOF analysis with a MassAR-
RAY Analyzer Compact mass spectrometer. Genotypes were
automatically assigned and manually confirmed using MassAR-
RAY TyperAnalyzer software version 4.0 (SequenomH Inc.).
We applied the following sample/SNP QC exclusions for these
de novo genotype data: sex inconsistencies, sample call rate ,98%
and exact HWE p-value,0.0001. The average assay call rate was
0.993. Overall, 806 samples and 23 SNPs passed our QC criteria
in the TEENAGE replication cohort. Linear regression analysis
under an additive genetic model, taking into account age and age
and BMI in each stratum (men, women and combined set), was
carried out using Plink [31].
HUNT and TwinFat studies: The HUNT study consisted of 1626
[28] and TwinFat consisted of 216 individuals [29,30] (Table 1
and Table S2).
Global meta-analysis
We performed meta-analysis for the 23 prioritised SNPs across
the discovery and all replication datasets, comprising a total of
22,376 individuals (12,031 women and 10,345 men). We
performed the same six sets of analyses as described for the
Figure 1. Study design. Each step includes non-overlapping,
independent datasets.
doi:10.1371/journal.pone.0031369.g001
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calculated using Quanto [32].
Results
We did not observe an excess of signals in the six meta-analyses
that were carried out. QQ and Manhattan plots for combined
analysis (adjusted for age and adjusted for age and BMI) are shown
in Figure 2. QQ and Manhattan plots for men and women are
shown in Figure S2.
Of the 31 SNPs initially taken forward, 4 showed association
with p,0.05 in replication set 1. Twenty one of 31 signals had
effects in the same direction as the discovery GWAS meta-analysis
(binomial p-value=0.07, given we expect 50% of signals to be in
the same direction by chance) (Table S4). Of the 23 SNPs
prioritised for stage 2 replication, 12 had effects in the same
direction as the GWAS meta-analysis (binomial p-value=1) and 1
SNP achieved p,0.05 in replication set 2 (Table S4).
There were no genome-wide significant findings in the global
meta-analysis of prioritised SNPs across all discovery and
replication samples (Table S4). Global meta-analysis results with
the greatest evidence of association (p#0.001) are displayed in
Table 2. We created forest plots for SNPs with p-value#0.001
with studies ordered by increasing age (Figure S3). Our study had
90% power at the genome-wide significance level (p=5610
28)t o
detect SNPs that explain 0.5% of the genetic variance in men (total
n=10,345), 0.4% in women (total n=12,031) and 0.2% in the
combined set (total n=22,376).
We compared the effect sizes of the initially prioritised 31 SNPs
between sexes in the discovery dataset. The effect sizes of loci
arising from the combined analyses across men and women are
comparable. However, we found heterogeneity in the effect
estimates between sexes for the loci prioritized on the basis of
the male-only or female-only analyses (Table S5).
The rs9939609 FTO SNP showed nominal evidence for
association in the age adjusted strata in men and in the combined
set across both sexes (Table 3). The adjustment for BMI almost
totally eliminates the effect of FTO on BC which is visible through
a ten-fold decrease of beta values (Table 3). If the FTO BC effect
were of the same magnitude as the rs9939609 FTO SNP effect on
Figure 2. Manhattan and QQ plots based on meta-analyses results of the discovery panel: a) combined set - age adjusted, b)
combined set - age and BMI adjusted.
doi:10.1371/journal.pone.0031369.g002
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significance level to detect it in the combined set, 57% power in
women and 40% power in men. We additionally examined 53
previously associated obesity (BMI, waist to hip ratio, weight)
SNPs with BC and found 20 SNPs showing p,0.05, across six
different strata in the discovery panel (binomial p=0.175). The
most associated SNP was rs6548238 from the TMEM18 gene with
p=8.15610
24 in the age adjusted stratum across both sexes.
Association analysis results for all 53 SNPs are presented in Table
S6.
We examined the association of 64 previously established T2D
loci with BC in our discovery cohort and found 25 SNPs showing
p,0.05, across six different strata in the discovery panel (binomial
p=0.11) (Table S7). We also examined 41 previously established
SNPs that influence glycaemic traits (fasting glucose, fasting
insulin, glycated haemoglobin, 2 h glucose test) and found 12
SNPs with p,0.05, across six different strata in the discovery
panel (binomial p=0.576) (Table S8).
Discussion
In this large-scale GWAS meta-analysis of BC we analysed a
total of 22,376 individuals (12,031 women and 10,345 men) of
European ancestry across 14 GWAS discovery datasets and 4
replication cohorts. We followed-up signals from various strata in a
two stage replication effort but found no signals reaching genome-
wide significance.
Our study had 90% power to detect SNPs that explain 0.2% of
the genetic variance in the combined set i.e. our study is well
powered to detect modest effects at common loci at the genome-
wide significance level (e.g. a risk allele with frequency 0.35 and
per-allele increase of 2 mm of BC). One of the weaknesses of this
study is that BC is not a clearly-characterised phenotype because it
is essentially a composite of muscle mass, skeletal size and fat
tissue, traits with distribution differences between sexes [1,2]. In
order to decrease potential misclassification of the phenotype and
to search for sex-specific BC effects we conducted analyses in men
and women separately. We also analysed the more powerful,
combined dataset in the search for shared loci underlying BC. Our
study focused on common variants only and has not examined the
effect of low frequency and rare variants on BC.
All association analyses were adjusted for age since BC varies
throughout the life of individuals. In young individuals BC may be
particularly different since it may reflect body development and
growth during adolescence. To avoid associations that may arise
because BC in adolescents might not be comparable with the
phenotypic measure of middle-aged and elder individuals, we
performed a sensitivity analysis by excluding studies with
adolescent participants. The results of our sensitivity analysis were
qualitatively similar to the results from the full-set discovery meta-
analysis (data not shown).
We have also examined the effects of top loci across all strata in
the discovery dataset in order to compare effect sizes between
sexes (Table S5). As expected, the effect sizes of loci prioritized
based on the combined male and female analyses are comparable
between men and women. However, when we examined the effect
estimates of loci prioritised on the basis of a specific sex analysis in
the opposite sex, we mainly observe heterogeneity i.e. effect sizes
from one sex analyses greatly differ in size or direction in the other
sex. This is corroborated with statistical evidence for heterogeneity
as evaluated through the I
2 measure. This may explain why the
combined analyses of these loci did not result in improved or
genome-wide significance. This additionally confirms that the BC
measure has different properties in men and women.
One of the aims of this study was to investigate if established
obesity and other fat distribution-associated loci also regulate
peripheral adiposity. We expected to see some overlap, since BC is
correlated with BMI (Table 1), but also to potentially detect new
loci that may explain the properties of peripheral adiposity since
fat is disproportionally distributed over the body. We examined
the well-established BMI-associated FTO gene variant [33,34] in
Table 2. Global meta-analysis results with p#0.001.
STRATUM SNP GENE EA EAF BETA SE P I
2 N
WOMEN (age adjusted) rs13097456 BDH1 T 0.304 0.152 0.043 4.21E-04 0.479 12108
WOMEN (age adjusted) rs9997081 LEF1 (37 kb away) T 0.133 20.195 0.061 0.001 0.348 12094
WOMEN (age &
BMI adjusted)
rs17665125 C2orf43, GDF7 (93 kb away) T 0.723 20.084 0.025 9.24E-04 0.559 12079
MEN (age adjusted) rs11908586 KCNG1 (130 kb away), NFATC2
(239 kb away)
G0 . 8 4 820.422 0.111 1.48E-04 0.099 10219
MEN (age & BMI adjusted) rs7176881 EIF2AK4 T0 . 1 5 3 20.221 0.057 1.07E-04 0.430 10203
COMBINED (age & BMI
adjusted)
rs1476587 DMTF1 (85 kb away), GRM3
(203 kb away)
G 0.141 0.283 0.063 6.50E-06 0.321 20674
EA - effect allele; EAF - effect allele frequency; SE - standard error; P - p-value; I
2- measure of heterogeneity; N - total number of samples.
doi:10.1371/journal.pone.0031369.t002
Table 3. Global meta-analysis results for the rs9939609 FTO
SNP.
STRATUM EA EAF BETA SE P I
2 N
WOMEN (age
adjusted)
T 0.565 20.052 0.035 0.137 0.552 11600
WOMEN (age &
BMI adjusted)
T 0.565 20.006 0.021 0.769 0.120 11493
MEN (age
adjusted)
T 0.575 20.113 0.054 0.036 0.545 9734
MEN (age & BMI
adjusted)
T 0.575 20.014 0.033 0.656 0.413 9719
COMBINED (age
adjusted)
T 0.570 20.073 0.029 0.013 0.605 21334
COMBINED (age
& BMI adjusted)
T 0.570 20.011 0.019 0.571 0.321 21306
EA - effect allele; EAF - effect allele frequency; SE - standard error; P - p-value; I
2-
measure of heterogeneity; N - total number of samples.
doi:10.1371/journal.pone.0031369.t003
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evidence for association with BC. On the basis of anthropometric
and animal model research it is shown that the FTO gene is
primarily associated with fat mass [34,35]. This may explain the
fact that we observe only nominal association with BC, since BC is
a composite measure of, both lean and fat mass. Of the 53
previously established obesity/adiposity loci we examined in the
discovery dataset, only one had p,0.001 (rs6548238 SNP in the
TMEM18, p=8.15610
24 in the combined-age adjusted set).
Variants in the TMEM18 gene were previously associated with
BMI, body weight and increased risk of childhood obesity
[33,34,36]. Willer et al showed that associations of the TMEM18
gene with BMI are, similarly as for the FTO gene, driven by
increased fat mass [33].
We have also investigated if established T2D loci and loci
implicated in glycaemic traits are associated with BC. We did not
detect strong evidence for association with BC. Only one
previously established T2D variant (rs11899863 in the THADA
gene) had p=0.001 in the men age-and-BMI adjusted set. This
gene was previously associated with thyroid adenomas [37] and
recently with gestational weight gain [38].
Within the power constraints of our study, the data suggest that
BC is not a good surrogate measure for overall adiposity genetics.
To get a better measure of muscularity we employed BMI
adjustments for a subset of our analyses, assuming that BMI is an
indirect measure of overall adiposity. This interpretation may not
be straightforward because BMI is stature-dependent and may
reflect lean tissue as well [13,34]. No genome-wide replicating
associations were identified.
In this large-scale GWAS meta-analysis for BC we have not
identified any signals reaching genome-wide significance and do
not observe robust association of previously established obesity loci
with BC. This may indicate that peripheral adiposity, measured
through BC, does not share similar biological patterns with overall
adiposity, measured through BMI, and that BC is not a good
measure of peripheral adiposity but mainly reflects muscularity.
We have also carried out six stratified analyses, which although
non-independent give rise to multiplicity issues. Any significant or
nominal associations would therefore need to be interpreted with
added caution. Large-scale collaborative efforts will be required to
achieve the necessary power to detect loci underpinning BC, and
detailed anthropometry will help deconvolute the determinants of
muscularity, adiposity and their distributions.
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